In the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial evaluating liraglutide (a GLP-1 analog), the observed mild elevations in pancreatic enzyme were not predictive of subsequent acute pancreatitis26. Here, GLP1R is linked to diabetes mellitus.